BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25701814)

  • 1. Structure-function analysis of SAP97, a modular scaffolding protein that drives dendrite growth.
    Zhang L; Hsu FC; Mojsilovic-Petrovic J; Jablonski AM; Zhai J; Coulter DA; Kalb RG
    Mol Cell Neurosci; 2015 Mar; 65():31-44. PubMed ID: 25701814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAP97 Binding Partner CRIPT Promotes Dendrite Growth
    Zhang L; Jablonski AM; Mojsilovic-Petrovic J; Ding H; Seeholzer S; Newton IP; Nathke I; Neve R; Zhai J; Shang Y; Zhang M; Kalb RG
    eNeuro; 2017; 4(6):. PubMed ID: 29218323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GluR1 controls dendrite growth through its binding partner, SAP97.
    Zhou W; Zhang L; Guoxiang X; Mojsilovic-Petrovic J; Takamaya K; Sattler R; Huganir R; Kalb R
    J Neurosci; 2008 Oct; 28(41):10220-33. PubMed ID: 18842882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide binding and NMR analysis of the interaction between SAP97 PDZ2 and GluR-A: potential involvement of a disulfide bond.
    von Ossowski L; Tossavainen H; von Ossowski I; Cai C; Aitio O; Fredriksson K; Permi P; Annila A; Keinänen K
    Biochemistry; 2006 May; 45(17):5567-75. PubMed ID: 16634638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CASK regulates SAP97 conformation and its interactions with AMPA and NMDA receptors.
    Lin EI; Jeyifous O; Green WN
    J Neurosci; 2013 Jul; 33(29):12067-76. PubMed ID: 23864692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the second PDZ domain of SAP97 in complex with a GluR-A C-terminal peptide.
    von Ossowski I; Oksanen E; von Ossowski L; Cai C; Sundberg M; Goldman A; Keinänen K
    FEBS J; 2006 Nov; 273(22):5219-29. PubMed ID: 17069616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the potential role of GluA4 carboxyl-terminus in PDZ interactions.
    Coleman SK; Cai C; Kalkkinen N; Korpi ER; Keinänen K
    PLoS One; 2010 Jan; 5(1):e8715. PubMed ID: 20090852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative N-terminal domains of PSD-95 and SAP97 govern activity-dependent regulation of synaptic AMPA receptor function.
    Schlüter OM; Xu W; Malenka RC
    Neuron; 2006 Jul; 51(1):99-111. PubMed ID: 16815335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAP97 controls the trafficking and resensitization of the beta-1-adrenergic receptor through its PDZ2 and I3 domains.
    Nooh MM; Naren AP; Kim SJ; Xiang YK; Bahouth SW
    PLoS One; 2013; 8(5):e63379. PubMed ID: 23696820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-angle X-ray scattering and NMR studies of the conformation of the PDZ region of SAP97 and its interactions with Kir2.1.
    Goult BT; Rapley JD; Dart C; Kitmitto A; Grossmann JG; Leyland ML; Lian LY
    Biochemistry; 2007 Dec; 46(49):14117-28. PubMed ID: 18004877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of SAP97 with minus-end-directed actin motor myosin VI. Implications for AMPA receptor trafficking.
    Wu H; Nash JE; Zamorano P; Garner CC
    J Biol Chem; 2002 Aug; 277(34):30928-34. PubMed ID: 12050163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAP97 concentrates at the postsynaptic density in cerebral cortex.
    Valtschanoff JG; Burette A; Davare MA; Leonard AS; Hell JW; Weinberg RJ
    Eur J Neurosci; 2000 Oct; 12(10):3605-14. PubMed ID: 11029631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synapse-associated protein 97 selectively associates with a subset of AMPA receptors early in their biosynthetic pathway.
    Sans N; Racca C; Petralia RS; Wang YX; McCallum J; Wenthold RJ
    J Neurosci; 2001 Oct; 21(19):7506-16. PubMed ID: 11567040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal SAP97 isoforms differentially regulate synaptic structure and postsynaptic surface pools of AMPA receptors.
    Goodman L; Baddeley D; Ambroziak W; Waites CL; Garner CC; Soeller C; Montgomery JM
    Hippocampus; 2017 Jun; 27(6):668-682. PubMed ID: 28244171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of different phases of AMPA receptor intracellular transport by 4.1N and SAP97.
    Bonnet C; Charpentier J; Retailleau N; Choquet D; Coussen F
    Elife; 2023 Apr; 12():. PubMed ID: 37079350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GluA1 promotes the activity-dependent development of motor circuitry in the developing segmental spinal cord.
    Jablonski AM; Kalb RG
    Ann N Y Acad Sci; 2013 Mar; 1279():54-9. PubMed ID: 23531002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine 893 is a target of regulatory thiol modifications of GluA1 AMPA receptors.
    von Ossowski L; Li LL; Möykkynen T; Coleman SK; Courtney MJ; Keinänen K
    PLoS One; 2017; 12(2):e0171489. PubMed ID: 28152104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAP97 blocks the RXR ER retention signal of NMDA receptor subunit GluN1-3 through its SH3 domain.
    Hong X; Avetisyan M; Ronilo M; Standley S
    Biochim Biophys Acta; 2015 Feb; 1853(2):489-99. PubMed ID: 25499266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stargazin and other transmembrane AMPA receptor regulating proteins interact with synaptic scaffolding protein MAGI-2 in brain.
    Deng F; Price MG; Davis CF; Mori M; Burgess DL
    J Neurosci; 2006 Jul; 26(30):7875-84. PubMed ID: 16870733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transsynaptic signaling by postsynaptic synapse-associated protein 97.
    Regalado MP; Terry-Lorenzo RT; Waites CL; Garner CC; Malenka RC
    J Neurosci; 2006 Feb; 26(8):2343-57. PubMed ID: 16495462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.